Catalent Pharma Solutions, Inc. - FORM 10-K - EX-32.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 - September 16, 2011

Attached files

file filename
10-K - FORM 10-K - Catalent Pharma Solutions, Inc.d232612d10k.htm
EX-2.5 - STOCK PURCHASE AGREEMENT - Catalent Pharma Solutions, Inc.d232612dex25.htm
EX-21.1 - LIST OF SUBSIDIARIES - Catalent Pharma Solutions, Inc.d232612dex211.htm
EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) - Catalent Pharma Solutions, Inc.d232612dex312.htm
EX-12.1 - STATEMENT REGARDING COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES - Catalent Pharma Solutions, Inc.d232612dex121.htm
EX-10.6 - LETTER AGREEMENT - Catalent Pharma Solutions, Inc.d232612dex106.htm
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) - Catalent Pharma Solutions, Inc.d232612dex311.htm
EX-32.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 - Catalent Pharma Solutions, Inc.d232612dex322.htm
EX-10.36 - FORM OF NONQUALIFIED STOCK OPTION AGREEMENT (DAVID HEYENS) - Catalent Pharma Solutions, Inc.d232612dex1036.htm

Exhibit 32.1

Certification of the Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report of Catalent Pharma Solutions, Inc. (the “Company”) on Form 10-K for the year ended June 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John R. Chiminski, Chief Executive Officer of the Company certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: September 16, 2011

 

/s/ John R. Chiminski

John R. Chiminski

President and Chief Executive Officer

Catalent Pharma Solutions, Inc. Reports